From: Incidence of proximal deep vein thrombosis in medical critical care patients
Characteristic | No DVT (133) | DVT (25) | p | Multivariable analysisa | |
---|---|---|---|---|---|
Adjusted OR (95% CI) | p | ||||
Age, median (IQR), years | 61 (45-75) | 72 (64-80) | 0.04 | 1.04b (1.01-1.07) | 0.02 |
Female sex, n (%) | 59 (44.4) | 17 (68) | 0.051 | 4.05 (1.51-12.3) | 0.01 |
BMI, median (IQR), kg/m2 | 21.6 (19-24.2) | 21.3 (19.2-24.4) | 0.83 | Â | Â |
Acute conditions, n (%) | Â | Â | Â | Â | Â |
Acute respiratory failure | 107 (80.5) | 22 (88) | 0.57 | Â | Â |
Sepsis | 104 (78.2) | 20 (80) | 0.99 | Â | Â |
Acute kidney injury | 37 (27.8) | 7 (28) | 0.99 | Â | Â |
Congestive heart failure | 9 (6.8) | 2 (8) | 0.69 | Â | Â |
COPD with acute exacerbation | 8 (6) | 2 (8) | 0.66 | Â | Â |
Cerebrovascular accident | 9 (6.8) | 0 (0) | 0.36 | Â | Â |
ARDS | 8 (6) | 1 (4) | 0.99 | Â | Â |
APACHE II, mean (SD), points | 20.8 (7.7) | 22.3 (5.7) | 0.26 | Â | Â |
History of cancer, n (%) | 22 (16.5) | 3 (12) | 0.77 | Â | Â |
History of previous VTE, n (%) | 1 (0.8) | 1 (4) | 0.29 | Â | Â |
RRT, n (%) | 17 (12.8) | 8 (32) | 0.03 | Â | Â |
Duration of RRT, median (IQR), days | 2 (1-19) | 6.5 (2.5-13.3) | 0.68 | Â | Â |
Platelet transfusion, n (%) | 27 (20.3) | 1 (4) | 0.08 | 0.07 (0.003-0.43) | 0.02 |
Use of vasopressor or inotropes, n (%) | 89 (66.9) | 18 (72) | 0.79 | Â | Â |
Use of NMBA, n (%) | 18 (13.6) | 6 (24) | 0.22 | Â | Â |
Central venous line, n (%) | 68 (51.1) | 17 (68) | 0.18 | Â | Â |
Internal jugular vein | 59 (44.4) | 14 (56) | 0.94 | Â | Â |
Femoral vein | 15 (11.3) | 9 (36) | 0.004 | 11.18 (3.19-44.83) | < 0.001 |
Subclavian vein | 5 (3.8) | 3 (12) | 0.11 | Â | Â |
Cubital vein | 8 (6) | 1 (4) | 0.99 | Â | Â |
Mechanical ventilation, n (%) | 111 (83.5) | 22 (88) | 0.77 | Â | Â |
Clinical probability at first 48Â h, n (%) | Â | Â | Â | Â | Â |
Low | 106 (79.7) | 15 (60) | 0.02 | Â | Â |
Moderate | 23 (17.3) | 6 (24) | Â | Â | Â |
High | 4 (3) | 4 (16) | Â | Â | Â |